Translationally Controlled Tumour Protein as a Novel Therapeutic Target in Pulmonary Arterial Hypertension
Background: Pulmonary arterial hypertension (PAH) is a multifaceted disease characterized by elevated pulmonary arterial pressure, right ventricular hypertrophy, and a poor prognosis. Pathological hallmarks of PAH include pulmonary vascular remodelling, pre-capillary arterial obliteration, and plexi...
| Main Author: | |
|---|---|
| Other Authors: | |
| Language: | en |
| Published: |
Université d'Ottawa / University of Ottawa
2016
|
| Subjects: | |
| Online Access: | http://hdl.handle.net/10393/35006 http://dx.doi.org/10.20381/ruor-5062 |